Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
1,664.90
-2.60 (-0.16%)
Jun 4, 2025, 3:29 PM IST
NSE:SUNPHARMA Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Market Capitalization | 3,994,653 | 4,162,126 | 3,888,242 | 2,358,729 | 2,194,737 | 1,434,322 | Upgrade
|
Market Cap Growth | 7.04% | 7.04% | 64.84% | 7.47% | 53.02% | 69.69% | Upgrade
|
Enterprise Value | 3,771,077 | 3,989,271 | 3,792,904 | 2,296,495 | 2,136,376 | 1,424,670 | Upgrade
|
Last Close Price | 1664.90 | 1734.70 | 1605.75 | 965.19 | 888.47 | 574.57 | Upgrade
|
PE Ratio | 36.51 | 38.08 | 40.60 | 27.84 | 67.06 | 49.39 | Upgrade
|
Forward PE | 32.03 | 35.80 | 42.36 | 28.97 | 28.54 | 26.49 | Upgrade
|
PS Ratio | 7.60 | 7.92 | 8.02 | 5.38 | 5.68 | 4.28 | Upgrade
|
PB Ratio | 5.51 | 5.74 | 5.79 | 3.98 | 4.30 | 2.90 | Upgrade
|
P/TBV Ratio | 7.36 | 7.67 | 8.38 | 6.16 | 6.23 | 4.16 | Upgrade
|
P/FCF Ratio | 33.45 | 34.85 | 39.14 | 82.08 | 29.30 | 28.69 | Upgrade
|
P/OCF Ratio | 28.39 | 29.58 | 32.04 | 47.56 | 24.43 | 23.25 | Upgrade
|
PEG Ratio | 2.26 | 2.46 | 2.97 | 1.99 | 1.46 | 1.31 | Upgrade
|
EV/Sales Ratio | 7.17 | 7.59 | 7.82 | 5.23 | 5.53 | 4.25 | Upgrade
|
EV/EBITDA Ratio | 25.02 | 26.44 | 29.46 | 19.71 | 21.04 | 17.07 | Upgrade
|
EV/EBIT Ratio | 30.18 | 31.89 | 36.05 | 24.68 | 26.19 | 22.17 | Upgrade
|
EV/FCF Ratio | 31.57 | 33.40 | 38.18 | 79.91 | 28.53 | 28.49 | Upgrade
|
Debt / Equity Ratio | 0.03 | 0.03 | 0.05 | 0.12 | 0.03 | 0.08 | Upgrade
|
Debt / EBITDA Ratio | 0.16 | 0.16 | 0.25 | 0.58 | 0.13 | 0.46 | Upgrade
|
Debt / FCF Ratio | 0.20 | 0.20 | 0.33 | 2.40 | 0.17 | 0.77 | Upgrade
|
Asset Turnover | 0.59 | 0.59 | 0.58 | 0.58 | 0.56 | 0.49 | Upgrade
|
Inventory Turnover | 1.05 | 1.05 | 1.08 | 1.12 | 1.17 | 1.05 | Upgrade
|
Quick Ratio | 2.09 | 2.09 | 1.82 | 1.36 | 1.37 | 1.20 | Upgrade
|
Current Ratio | 2.89 | 2.89 | 2.56 | 2.00 | 2.03 | 1.89 | Upgrade
|
Return on Equity (ROE) | 15.71% | 15.71% | 15.20% | 15.43% | 6.74% | 4.61% | Upgrade
|
Return on Assets (ROA) | 8.81% | 8.81% | 7.91% | 7.73% | 7.42% | 5.91% | Upgrade
|
Return on Capital (ROIC) | 10.77% | 10.77% | 9.63% | 9.81% | 9.64% | 7.25% | Upgrade
|
Return on Capital Employed (ROCE) | 16.90% | 16.90% | 15.40% | 15.30% | 15.50% | 12.50% | Upgrade
|
Earnings Yield | 2.74% | 2.63% | 2.46% | 3.59% | 1.49% | 2.02% | Upgrade
|
FCF Yield | 2.99% | 2.87% | 2.56% | 1.22% | 3.41% | 3.49% | Upgrade
|
Dividend Yield | 0.96% | 0.92% | 0.84% | 1.19% | 1.13% | 1.31% | Upgrade
|
Payout Ratio | 33.07% | 33.07% | 30.26% | 29.73% | 65.97% | 53.70% | Upgrade
|
Buyback Yield / Dilution | 0.11% | 0.11% | - | - | - | - | Upgrade
|
Total Shareholder Return | 1.07% | 1.03% | 0.84% | 1.19% | 1.13% | 1.31% | Upgrade
|
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.